Msd Sub Merck patents expiration

1. Isentress patents expiration

ISENTRESS's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8852632 MSD SUB MERCK Pharmaceutical formulation containing a release rate controlling composition
Jan, 2028

(4 years from now)

US8771733 MSD SUB MERCK Pharmaceutical composition containing an anti-nucleating agent
Jun, 2030

(6 years from now)

Drugs and Companies using RALTEGRAVIR POTASSIUM ingredient

Market Authorisation Date: 12 October, 2007

Treatment: Treatment of hiv infection


How can I launch a generic of ISENTRESS before it's drug patent expiration?
More Information on Dosage

ISENTRESS family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic